People who have had a bleed in their brain or have tiny spots of bleeding on scans often worry about taking blood thinners. They fear that preventing a clot might cause another bleed. This study looked at a different question. It asked if the amount of small-vessel disease in the brain predicts the risk of a stroke or heart attack. The answer is yes. The more small-vessel disease a person has, the higher their risk of a stroke that blocks blood flow. This matters because these patients are often told to avoid strong blood thinners. But avoiding them might leave them unprotected against a clotting stroke.
The researchers looked at data from a large group of patients. They included 1,454 people who were prone to bleeding in the brain. These patients either had cerebral microbleeds or had had an intracerebral hemorrhage before. The team measured the amount of small-vessel disease in their brains. They grouped these patients into three categories based on their scores. They followed these patients for an average of 1.9 years. During this time, they watched for strokes and heart events.
The results showed a clear pattern. Patients with the highest scores had much higher rates of ischemic stroke. The risk was 2.72 times higher for those with the most disease compared to those with the least. They also saw higher rates of major adverse cardiovascular events. These are serious heart or blood vessel problems. The risk was 2.34 times higher in the high-score group. The numbers for bleeding strokes were higher too, but the study could not prove this was a real increase. The numbers were not statistically significant. This means the data did not show a clear link to bleeding strokes.
Safety was a major concern for this group. These patients have a history of bleeding. Adding more risk factors is always a worry. The study did not find new safety issues with the disease itself. The concern is balancing the risk of a clot against the risk of a bleed. The data suggests that having a lot of small-vessel disease means a person is at higher risk for a clotting stroke. This risk exists even if the person has a history of bleeding. It is important to consider this when making treatment plans.
This study has some limits. It was a post hoc analysis. This means the researchers looked at data after the main trial was done. They used math models to find links between the disease scores and the events. These links show association, not cause and effect. We do not know if the disease scores caused the strokes. We also do not know if treating the disease would lower the risk. The link to bleeding strokes was not strong enough to be certain. People should not change their medication based on this single study. They should talk to their doctor about their specific risks.
For patients right now, this means high small-vessel disease burden may reflect elevated ischemic risk. It warrants careful consideration of ischemic stroke prevention. Even in patients with hemorrhagic potential, the risk of a clotting stroke is real. Doctors need to weigh this risk carefully. They must consider the benefits of preventing a clot versus the risk of a bleed. This study helps explain why some patients get strokes despite having bleeding risks. It shows that the disease in the brain is a marker for future trouble. Understanding this helps doctors make better choices for their patients.